{"id":"W3007085808","doi":"10.1002/ajh.25766","title":"Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group","year":2020,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Ibrutinib; IGHV@; Rituximab; Oncology; Gastroenterology; Surgery; Chronic lymphocytic leukemia; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009707335,0.0006003764,0.001736459,0.0004324958,0.0003138572,0.001470309,0.0005318745,0.0007928885,0.0007754486],"category_scores_gemma":[0.004233585,0.0002865496,0.001613724,0.0007715005,0.0004998861,0.0008467069,0.0003044847,0.001110027,0.0001617668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007387105,"about_ca_system_score_gemma":0.000818509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005434207,"about_ca_topic_score_gemma":0.001368358,"domain_scores_codex":[0.9970686,0.002214604,0.000178158,0.000206719,0.0001876777,0.0001442216],"domain_scores_gemma":[0.9960403,0.001335888,0.001302392,0.0003118177,0.0002978701,0.0007116176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6883104,0.005319017,0.1447637,0.001373468,0.008134308,0.0002197113,0.0003503661,0.001429528,0.006327923,0.0001963377,0.002444515,0.1411307],"study_design_scores_gemma":[0.3300534,0.205528,0.4337039,0.0005959258,0.01212749,0.0006307478,0.0002147144,0.002640615,0.002321228,0.00029421,0.01180202,0.00008775993],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788205,0.01838765,0.0003310058,0.0003821386,0.00006429332,0.0004035711,0.0007647315,0.00002040409,0.0008257069],"genre_scores_gemma":[0.9913788,0.004734294,0.0006412219,0.0005637686,0.0002238344,0.0004550345,0.001666455,0.00001009394,0.0003263586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009707335,"threshold_uncertainty_score":0.0513379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07603734731203367,"score_gpt":0.4028478104530401,"score_spread":0.3268104631410064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}